Profile data is unavailable for this security.
About the company
T.Man Pharmaceutical Public Company Limited is engaged in purchasing, importing, manufacturing, original equipment manufacturing, distributing and exporting of modern medicines, traditional medicine, dietary supplements, and health care products for the healthcare industry with subsidiaries as manufacturers. Its segments include manufactured products under own brand, manufactured products under third parties’ brand and trading products. With a diverse range of manufacturing machinery, it can produce various types of pharmaceutical products, meeting the needs of every consumer. Its production capabilities include tablets, capsules, powders, liquids, and semisolids. It offers capsule products, including both hard and soft capsules in various sizes, all made with imported, high-quality raw materials. Its product range covers a wide range of diseases and comes in various forms, including uncoated tablets, sugar-coated tablets, film-coated tablets, enteric-coated tablets, and suppositories.
- Revenue in THB (TTM)2.11bn
- Net income in THB419.13m
- Incorporated2023
- Employees--
- LocationT Man Pharmaceutical PCL69/1 Soi Bangkhunthian 14Samaedum, BangkhunthianBANGKOK 10150ThailandTHA
- Phone+66 24151007
- Fax+66 24161241
- Websitehttps://www.tmanpharma.in.th/en/home-en/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mediwound Ltd | 704.73m | -698.86m | 6.18bn | 100.00 | -- | 8.51 | -- | 8.77 | -2.16 | -2.16 | 2.18 | 1.92 | 0.3311 | 5.53 | 6.55 | 201,410.00 | -32.83 | -24.48 | -49.28 | -32.92 | 13.25 | 43.27 | -99.17 | -38.43 | 1.51 | -3.26 | 0.2623 | -- | -29.48 | 40.60 | 65.73 | -- | 64.66 | -- |
| Zota Health Care Ltd | 820.80m | -100.39m | 6.21bn | 445.00 | -- | -- | 3,209.69 | 7.56 | -9.27 | -9.27 | 76.32 | -- | -- | -- | -- | 4,452,605.00 | -- | -1.38 | -- | -1.85 | 49.86 | 35.95 | -12.23 | -1.33 | -- | -2.87 | -- | -- | 28.96 | 16.08 | -148.54 | -- | 39.85 | 0.00 |
| Animalcare Group Plc | 3.30bn | 208.03m | 6.34bn | 226.00 | 30.60 | 1.47 | 11.52 | 1.92 | 0.0775 | 0.3033 | 1.23 | 1.61 | 0.6287 | 2.76 | 5.63 | 329,885.00 | 3.96 | 0.3272 | 4.71 | 0.3866 | 57.82 | 54.92 | 6.30 | 0.5484 | 2.67 | 7.17 | 0.0425 | 599.95 | 3.82 | 0.5138 | -38.98 | -- | -11.79 | 2.59 |
| T Man Pharmaceutical PCL | 2.11bn | 419.13m | 6.44bn | -- | 15.37 | 3.66 | 27.86 | 3.05 | 1.05 | 1.05 | 5.29 | 4.39 | 0.8588 | 2.17 | 3.94 | -- | 17.02 | -- | 25.59 | -- | 46.86 | -- | 19.82 | -- | 1.15 | 34.19 | 0.1052 | -- | -2.20 | -- | -8.82 | -- | -- | -- |
| JG Chemicals Ltd | -41.42bn | -41.42bn | 6.44bn | 56.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -14.90 | -- | -43.84 | -- | -- | -- |
| Ascletis Pharma Inc | 48.86m | -1.25bn | 6.64bn | 219.00 | -- | 0.6513 | -- | 135.99 | -0.2681 | -0.2681 | 0.0105 | 2.32 | 0.0041 | 1.34 | 3.58 | 49,619.50 | -10.47 | -6.43 | -10.85 | -6.64 | -125.17 | 35.67 | -2,561.69 | -243.38 | 24.31 | -- | 0.004 | -- | 4.63 | -19.39 | 54.04 | -- | -20.44 | -- |
| Formosa Pharmaceuticals Inc | 143.46m | -320.22m | 6.68bn | -- | -- | 5.47 | -- | 46.58 | -2.22 | -2.22 | 0.9963 | 7.54 | 0.0803 | -- | 1.61 | -- | -17.91 | -40.34 | -19.62 | -44.21 | 86.96 | -- | -223.16 | -2,488.28 | -- | -- | 0.0277 | -- | 2,270.49 | -- | 20.75 | -- | -42.98 | -- |
| Essex Bio-Technology Ltd | 7.28bn | 1.18bn | 6.71bn | 1.46k | 5.85 | 0.7406 | 4.70 | 0.9218 | 0.4499 | 0.4499 | 2.73 | 3.55 | 0.5587 | 2.62 | 2.73 | 1,093,064.00 | 9.07 | 11.20 | 12.10 | 14.73 | 89.78 | 86.01 | 16.24 | 19.77 | 1.61 | -- | 0.1397 | 16.16 | 29.51 | 7.72 | 22.11 | 3.56 | 7.29 | 7.39 |
| Jacobson Pharma Corporation Ltd | 6.60bn | 945.34m | 6.75bn | 1.72k | 6.85 | 0.6261 | 4.26 | 1.02 | 0.1095 | 0.1391 | 0.7644 | 1.20 | 0.3311 | 2.47 | 6.37 | 851,885.10 | 4.74 | 4.30 | 5.76 | 5.57 | 42.27 | 41.25 | 14.32 | 13.73 | 1.73 | 5.33 | 0.2382 | 40.62 | 15.79 | -0.1401 | 1.31 | -3.05 | 24.06 | 4.10 |
| Pyridam Farma Tbk PT | 2.96bn | -560.45m | 6.99bn | 1.33k | -- | 2.64 | -- | 2.36 | -49.15 | -49.15 | 195.71 | 106.69 | 0.3606 | 2.65 | 3.33 | 1,126,088,000.00 | -6.82 | 6.31 | -10.49 | 8.07 | 27.38 | 42.56 | -18.91 | 8.83 | 0.5175 | -1.14 | 0.764 | -- | -1.87 | 22.89 | -130.96 | -- | 2.93 | -- |
